Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Checkmate Pharmaceuticals
1 Broadway, 14th Floor
Cambridge, MA 02142
Phone: 617-682-3625
http://checkmatepharma.com/

Checkmate Pharmaceuticals is a research and development company pursuing a novel approach to specifically activating the innate arm of the immune system to recognize and ultimately destroy tumor cells. The company is leveraging their expertise and the vast body of knowledge in the field of CpG oligonucleotides and is validating an approach that will combine the ability of CpG DNA to activate an anti-tumor T cell response with checkpoint inhibition to overcome a tumor's ability to mute the immune response.

Key Contact
NameTitleE-Mail
Art KriegCEOakrieg@checkmatepharma.com


Funding Events
DateAmountTypeInvestors
08/12/15$20,000,000Series A Sofinnova Ventures
VenBio
06/16/17$27,000,000Series B F-Prime Capital Partners  
Sofinnova Ventures
VenBio
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.